147 related articles for article (PubMed ID: 36110576)
1. Expression and the Prognostic Value of Biglycan in Gastric Cancer.
Hu S; Li P; Wang C; Liu X
Comput Math Methods Med; 2022; 2022():2656480. PubMed ID: 36110576
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
Schulz GB; Grimm T; Sers C; Riemer P; Elmasry M; Kirchner T; Stief CG; Karl A; Horst D
Urol Oncol; 2019 Aug; 37(8):530.e9-530.e18. PubMed ID: 31176613
[TBL] [Abstract][Full Text] [Related]
3. Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer.
Wang B; Li GX; Zhang SG; Wang Q; Wen YG; Tang HM; Zhou CZ; Xing AY; Fan JW; Yan DW; Qiu GQ; Yu ZH; Peng ZH
Exp Biol Med (Maywood); 2011 Nov; 236(11):1247-53. PubMed ID: 21998129
[TBL] [Abstract][Full Text] [Related]
4. Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers.
Zhao SF; Yin XJ; Zhao WJ; Liu LC; Wang ZP
Oncol Lett; 2020 Mar; 19(3):1673-1682. PubMed ID: 32194659
[TBL] [Abstract][Full Text] [Related]
5. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
Jacobsen F; Kraft J; Schroeder C; Hube-Magg C; Kluth M; Lang DS; Simon R; Sauter G; Izbicki JR; Clauditz TS; Luebke AM; Hinsch A; Wilczak W; Wittmer C; Büscheck F; Höflmayer D; Minner S; Tsourlakis MC; Huland H; Graefen M; Budäus L; Thederan I; Salomon G; Schlomm T; Melling N
Neoplasia; 2017 Sep; 19(9):707-715. PubMed ID: 28830008
[TBL] [Abstract][Full Text] [Related]
7. BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer.
Wu H; Xiang Z; Huang G; He Q; Song J; Dou R; Yang C; Wang S; Xiong B
Int J Biol Sci; 2023; 19(2):465-483. PubMed ID: 36632455
[TBL] [Abstract][Full Text] [Related]
8. Biglycan enhances gastric cancer invasion by activating FAK signaling pathway.
Hu L; Duan YT; Li JF; Su LP; Yan M; Zhu ZG; Liu BY; Yang QM
Oncotarget; 2014 Apr; 5(7):1885-96. PubMed ID: 24681892
[TBL] [Abstract][Full Text] [Related]
9. Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.
Andrlová H; Mastroianni J; Madl J; Kern JS; Melchinger W; Dierbach H; Wernet F; Follo M; Technau-Hafsi K; Has C; Rao Mittapalli V; Idzko M; Herr R; Brummer T; Ungefroren H; Busch H; Boerries M; Narr A; Ihorst G; Vennin C; Schmitt-Graeff A; Minguet S; Timpson P; Duyster J; Meiss F; Römer W; Zeiser R
Oncotarget; 2017 Jun; 8(26):42901-42916. PubMed ID: 28476030
[TBL] [Abstract][Full Text] [Related]
10. Relationship of biglycan and decorin expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma.
Liu M; Wang W; Piao S; Shen Y; Li Z; Ding W; Li J; Saiyin W
J Oral Pathol Med; 2023 Jan; 52(1):20-28. PubMed ID: 36308714
[TBL] [Abstract][Full Text] [Related]
11. Identification of BGN and THBS2 as metastasis-specific biomarkers and poor survival key regulators in human colon cancer by integrated analysis.
He Z; Lin J; Chen C; Chen Y; Yang S; Cai X; He Y; Liu S
Clin Transl Med; 2022 Nov; 12(11):e973. PubMed ID: 36377223
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract][Full Text] [Related]
13. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
[No Abstract] [Full Text] [Related]
14. The lncRNA SEMA3B-AS1/HMGB1/FBXW7 Axis Mediates the Peritoneal Metastasis of Gastric Cancer by Regulating BGN Protein Ubiquitination.
Huang G; Xiang Z; Wu H; He Q; Dou R; Yang C; Song J; Huang S; Wang S; Xiong B
Oxid Med Cell Longev; 2022; 2022():5055684. PubMed ID: 35273678
[TBL] [Abstract][Full Text] [Related]
15. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
16. Identification of Differentially Expressed Genes Reveals BGN Predicting Overall Survival and Tumor Immune Infiltration of Gastric Cancer.
Chen W; Yang Z
Comput Math Methods Med; 2021; 2021():5494840. PubMed ID: 34868341
[TBL] [Abstract][Full Text] [Related]
17. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of the extracellular matrix component Biglycan regulated by Hedgehog signalling promotes colorectal cancer cell proliferation.
Zeng S; Zhou F; Wang Y; Zhai Z; Xu L; Wang H; Chen X; Luo S; Cheng M
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):243-251. PubMed ID: 35130618
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma.
Shao C; Cheng C; Shao Q; Chen B
Int J Gen Med; 2021; 14():3497-3509. PubMed ID: 34295178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]